EFFECTS OF LIPOSOME-ENCAPSULATED DRUGS ON MACROPHAGES - COMPARATIVE ACTIVITY OF THE DIAMIDINE 4',6-DIAMIDINO-2-PHENYLINDOLE AND THE PHENANTHRIDINIUM SALTS ETHIDIUM-BROMIDE AND PROPIDIUM IODIDE
J. Bakker et al., EFFECTS OF LIPOSOME-ENCAPSULATED DRUGS ON MACROPHAGES - COMPARATIVE ACTIVITY OF THE DIAMIDINE 4',6-DIAMIDINO-2-PHENYLINDOLE AND THE PHENANTHRIDINIUM SALTS ETHIDIUM-BROMIDE AND PROPIDIUM IODIDE, Biochimica et biophysica acta. Biomembranes, 1373(1), 1998, pp. 93-100
Liposomes can be used for the intracellular delivery of drugs into mac
rophages. Previously, we developed a liposome-mediated macrophage 'sui
cide' technique based on the intraphagocytic accumulation of the lipos
omally delivered bisphosphonate clodronate. Later we found that the di
amidine propamidine is even more effective in this approach. In the pr
esent study it is shown that liposome-encapsulated 4',6-diamidino-2-ph
enylindole (L-DAPI), another well known DNA-binding diamidine, is the
most effective drug in killing liver macrophages (Kupffer cells), when
intravenously administered in rat. Compared to liposome-encapsulated
propamidine (L-propamidine) it showed about 10-fold more activity on a
molar basis. Furthermore, L-DAPI was found to induce cell death by in
ducing apoptosis, The structurally strongly related phenanthridinium s
alts ethidium bromide (EB) and propidium iodide (PI) exert marked diff
erences in their efficacy. Whereas liposome-encapsulated PI (L-PI) was
about 5 times more active in killing macrophages than L-propamidine,
liposome-encapsulated EB (L-EB) showed a strongly reduced activity (10
times less than L-PI). As is shown here, PI remains mainly encapsulat
ed in liposomes, while substantial amounts of EB leak out of liposomes
. This may very well explain the differences in in vivo activity betwe
en L-EB and L-PI. (C) 1998 Elsevier Science B.V. All rights reserved.